The Phase 2, Randomized, Placebo-controlled PRECEDENT Trial of SAGE-718 in Patients With Parkinson's Disease Cognitive Impairment: Clinical Trial in Progress

被引：0
|
作者：
Bullock, Amy [1 ]
Koenig, Aaron [1 ]
Paumier, Katrina [1 ]
Freitag, Emily [1 ]
Wald, Jeffrey [1 ]
Park, Sola [1 ]
Quirk, Michael [1 ]
Billet, Jennifer Petrillo [1 ]
Doherty, James [1 ]
机构：
[1] Sage Therapeut Inc, Cambridge, MA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203649
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2-11.005
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
  • [22] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [23] Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial
    Lim, Jae -Sung
    Lee, Juneyoung
    Kang, Yeonwook
    Park, Hyun-Tae
    Kim, Dong-Eog
    Cha, Jae-Kwan
    Park, Tai Hwan
    Heo, Jae-Hyuk
    Lee, Kyung Bok
    Park, Jong -Moo
    Oh, Mi Sun
    Kim, Eung-Gyu
    Chang, Dae-Il
    Heo, Sung Hyuk
    Park, Man-Seok
    Park, HyunYoung
    Yi, SangHak
    Lee, Yeong Bae
    Park, Kwang-Yeol
    Lee, Soo Joo
    Kim, Jae Guk
    Lee, Jun
    Cho, Kyung-Hee
    Rha, Joung-Ho
    Kim, Yeong-In
    Lee, Jun Hong
    Choi, Jay Chol
    Oh, Kyung-Mi
    Kwon, Jee-Hyun
    Kim, Chulho
    Park, Jong-Ho
    Jung, Keun-Hwa
    Sung, Sang Min
    Chung, Jong-Won
    Lee, Yong-Seok
    Kim, Hahn Young
    Cho, Hyun-Ji
    Park, Jeong Wook
    Moon, Won-Jin
    Bae, Hee-Joon
    CONTEMPORARY CLINICAL TRIALS, 2023, 126
  • [24] A Randomized, Phase 2a, Double-blind, Placebo-controlled Clinical Trial with NE3107 Adjunctive to Carbidopa/Levodopa in Patients with Parkinson's Disease
    Aldred, J.
    Rodriguez, R.
    Rivera-Rivera, E.
    Isaacson, S.
    Kumar, R.
    Ellenbogen, A.
    Ahlem, C.
    Reading, C.
    Palumbo, J.
    Osman, N.
    Lang, A.
    MOVEMENT DISORDERS, 2023, 38 : S1 - S1
  • [25] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [26] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [27] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [28] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
  • [29] A Pilot Randomized Placebo-Controlled Trial of Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
    Altman, Robert
    Lang, Anthony
    Munhoz, Renato
    Charand, Katia
    Wadup, Lisa
    Postuma, Ronald
    NEUROLOGY, 2011, 76 (09) : A275 - A275
  • [30] Effects of working memory training in patients with Parkinson's disease without cognitive impairment: A randomized controlled trial
    Ophey, Anja
    Giehl, Kathrin
    Rehberg, Sarah
    Eggers, Carsten
    Reker, Paul
    van Eimeren, Thilo
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2020, 72 : 13 - 22
12345